Percutaneous endovascular intervention for clinically symptomatic FMD in the renal arteries is technically successful, safe, and durable. Most patients have immediate clinical benefit, with continued long-term results out to 5 years. It appears that the presence of existing renal pathology and markers of prediabetic state are associated with recurrence of hypertensive symptoms.